{"componentChunkName":"component---src-templates-study-details-page-js","path":"/en/study/APV102002","result":{"data":{"studyNotFoundJson":{"title":"Study not found","content":{"childMarkdownRemark":{"html":"<p>If you entered a web address please check it was correct.</p>\n<p>You can also try <a href=\"/en/studies\">Search Page</a> to find the study you are looking for.</p>"}}},"trialDetailsJson":{"title":"Details Page","returnSearch":"Back to search results","description":"Study Description","identifier":"ViiV Study ID","clinicalID":"Clinicaltrials.gov Identifier","EudraCtID":"EudraCT Number","resultsAvailable":"Has Results Available Below","docAvailable":"Has Results Document Available","studyOverview":"Study Overview","overviewSection":{"conditionsDisplay":"Medical Conditions","product":"Product","collaborators":"Collaborators","dates":"Date","studyType":"Type","phase":"Phase","gender":"Gender","age":"Age","acceptVolunteers":"Accepts Healthy Volunteers"},"studyDocuments":"Study Documents","noDocuments":"No documents available","studyDocumentsAdditionalText":"If you wish to request for Full Study Report, please contact - ","studyDocumentsAdditionalEmail":"GSKClinicalSupportHD@gsk.com","isReleased":{"firstPart":"This study has Protocol and Result summary on ClinicalTrial.gov. Click","secondPart":"to learn more.","linkText":"here"},"mapLocations":"Locations","centralContact":"Central Contact","centralPhone":"Central Contact Phone","centralEmail":"Central Contact Email","mapSection":{"site":"GSK Investigational Site","condition":"Condition","id":"Study ID","city":"City","state":"State","zip":"Zip","country":"Country"},"studyDesign":"Study Design","designSection":{"purpose":"Primary Purpose","allocation":"Allocation","study_design":"Study Design","study_classification":"Study Classification","masking":"Masking","masked_subject":"Masked Subject","masked_caregiver":"Masked Caregiver","masked_investigator":"Masked Investigator","masked_assessor":"Masked Assessor","primary_outcomes":"Primary Outcomes","secondary_outcomes":"Secondary Outcomes","arms":"Arms","interventions":"Interventions","keyword":"Keyword","inclusionTitle":"Inclusion Criteria","exclusionTitle":"Exclusion Criteria","criteriaText":"Inclusion/Exclusion Criteria","criteria_button":"Click to view inclusion/exclusion criteria","enrollment":"Enrollment","clinicalPublications":"Clinical Publications"},"popoversText":{"studyId":{"childMarkdownRemark":{"html":"<p>A unique number for a study given by ViiV.</p>"}},"ctGov":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the US clinicaltrials.gov register. Click this link to go to the entry for this study on Clinicaltrials.gov where you will be able to see protocol and results summaries where available.</p>"}},"eudraCT":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the EU clinicaltrials.eu register. Click this link to go to the entry for this study on clinicaltrials.eu where you will be able to see protocol and results summaries where available.</p>"}}}},"site":{"siteMetadata":{"siteUrl":"https://www.viiv-studyregister.com"}},"studyDetails":{"nct_number":"NCT00144833","ctis_id":"","HasResults":"false","IpdAccessCriteria":"","IpdDescription":"","IpdInfoTypeAnalyticCode":"","IpdInfoTypeIcf":"","IpdInfoTypeCsr":"","IpdInfoTypeProtocol":"","IpdInfoTypeSap":"","IpdTimeFrame":"","IpdUrl":"","IsFlexibleTrial":false,"IsReleasedToCtGov":"true","MaskingInfo":{"masked_assessor":"false","masked_caregiver":"false","masked_investigator":"false","masked_subject":"false","masking_description":"","no_masking":""},"PatientLevelData":"false","SharingIpd":"","acronym":"","allocation":"Randomized","arm_groups":[],"assignment":"Parallel Assignment","brief_summary":"For HIV-infected individuals with highly resistant viruses, higher drug levels may be required to block the virus. This study investigates that concept by comparing the efficacy of standard fosamprenavir/ritonavir to an increased dose of boosted fosamprenavir and to a combination of fosamprenavir (increased dose)/lopinavir/ritonavir.","brief_summary_OneLinkTx":"","brief_title_OneLinkTx":"","brief_title":"Open Label Study of 908/RTV in Combination with other PIs for the Treatment of Multi PI-Experienced HIV Subjects","conditions":[{"DisplayValue":"Human Immunodeficiency Virus (HIV)","DisplayValue_OneLinkTx":"","InternalValue":"CON_HIV","LookupValue":"HIV-1 Infection","LookupValue_OneLinkTx":""}],"created_date":"09/15/2018 18:04:24","criteria":"Inclusion criteria: - Multiple protease-inhibitors experienced HIV-1 infected individuals experiencing virological failure and who's virus is not fully resistant to boosted fosamprenavir and boosted lopinavir based on genotypic resistance tests. Exclusion criteria: - No full resistance to FPV/r or LPV/r - Planned use of NNRTIs as part of the study salvage regimen - Application of additional exclusion criteria as determined by physician.","detailed_description":"A Phase III, Randomized, Controlled, Open-label, Multicentre, Three Arm Study to Compare the Efficacy and Safety of a Dual-boosted HIV-1 Protease Inhibitor regimen of Fosamprenavir/Lopinavir/Ritonavir 1400mg/533mg/133mg Twice Daily and an Increased Dosage Regimen of FPV/RTV 1400mg/100mg BID Versus the Standard Dosage Regimen of FPV/RTV 700mg/100mg BID for 24 Weeks in Multiple-PI Experienced, HIV-infected Adults Experiencing Virological Failure","display_gender":"Both","display_gender_internal":"GENDER_ALL","display_phase":"Phase 3","display_phase_internal":"PHASE_3","display_status":"Completed","display_status_internal":"RECSTATUS_I_COMPLETED","endpoint":"","enrollment":"150","exclusion":"","gender":"Both","gender_based":"","gender_description":"","healthy_volunteers":"No","id":"dff5a903-1784-5e3f-a458-bb440d9e457a","internal":{"content":null,"contentDigest":"c1a4cc90af03ef737523cf9b3afc38e5","description":null,"fieldOwners":null,"mediaType":null,"ignoreType":null,"owner":"default-site-plugin","type":"studyDetails"},"inclusion":"Inclusion criteria: - Multiple protease-inhibitors experienced HIV-1 infected individuals experiencing virological failure and who's virus is not fully resistant to boosted fosamprenavir and boosted lopinavir based on genotypic resistance tests. Exclusion criteria: - No full resistance to FPV/r or LPV/r - Planned use of NNRTIs as part of the study salvage regimen - Application of additional exclusion criteria as determined by physician.","interventions":[{"arm_group_label":"","intervention_description":"","intervention_name":"fosamprenavir/ritonavir (700mg/100mg BID)","intervention_type":"Drug"},{"arm_group_label":"","intervention_description":"","intervention_name":"fosamprenavir/ritonavir (1400mg/100mg BID)","intervention_type":"Drug"},{"arm_group_label":"","intervention_description":"","intervention_name":"fosamprenavir/lopinavir/ritonavir (1400mg/533mg/100mg BID)","intervention_type":"Drug"}],"interventional_subtype":"Treatment","is_fda_regulated":null,"is_high_value":false,"is_ind_study":false,"keywords":["Protease inhibitors-experienced HIV-1 infected patients","Highly-resistant HIV-1","Dual boosted Pis","fosamprenavir","lopinavir"],"last_follow_up_date":null,"links":[],"locations":[{"City":"Bruxelles","Latitude":"50.8427501","CountryDisplay":"Belgium","Longitude":"4.3515499","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"1000","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Ferrara","Latitude":"44.8524824","CountryDisplay":"Italy","Longitude":"11.7193789","Name":"GSK Investigational Site","StateDisplay":"Emilia-Romagna","PostalCode":"44100","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Bagno a Ripoli (FI)","Latitude":"43.7592388","CountryDisplay":"Italy","Longitude":"11.2920619","Name":"GSK Investigational Site","StateDisplay":"Toscana","PostalCode":"50126","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Montreal","Latitude":"45.5152072","CountryDisplay":"Canada","Longitude":"-73.5562284","Name":"GSK Investigational Site","StateDisplay":"Quebec","PostalCode":"H2L 5B1","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Sainte-Foy","Latitude":"46.7691394","CountryDisplay":"Canada","Longitude":"-71.2832751","Name":"GSK Investigational Site","StateDisplay":"Quebec","PostalCode":"G1V 4G2","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Marid","Latitude":"40.4473608","CountryDisplay":"Spain","Longitude":"-3.7384311","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"28040","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Paris","Latitude":"48.8785618","CountryDisplay":"France","Longitude":"2.3603689","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"75010","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Pavia","Latitude":"45.1847248","CountryDisplay":"Italy","Longitude":"9.1582069","Name":"GSK Investigational Site","StateDisplay":"Lombardia","PostalCode":"27100","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Roma","Latitude":"41.9209393","CountryDisplay":"Italy","Longitude":"12.409403","Name":"GSK Investigational Site","StateDisplay":"Lazio","PostalCode":"00168","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Genova","Latitude":"44.4013771","CountryDisplay":"Italy","Longitude":"8.9341937","Name":"GSK Investigational Site","StateDisplay":"Liguria","PostalCode":"16128","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Torino","Latitude":"45.0963655","CountryDisplay":"Italy","Longitude":"7.6636292","Name":"GSK Investigational Site","StateDisplay":"Piemonte","PostalCode":"10149","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Padova","Latitude":"45.397898","CountryDisplay":"Italy","Longitude":"11.9046617","Name":"GSK Investigational Site","StateDisplay":"Veneto","PostalCode":"35128","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Madrid","Latitude":"40.4765501","CountryDisplay":"Spain","Longitude":"-3.7003632","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"28029","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Madrid","Latitude":"40.4473608","CountryDisplay":"Spain","Longitude":"-3.7384311","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"28040","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Birmingham","Latitude":"52.4366501","CountryDisplay":"United Kingdom","Longitude":"-1.9375135","Name":"GSK Investigational Site","StateDisplay":"Warwickshire","PostalCode":"B29 6JD","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"London","Latitude":"51.5531762","CountryDisplay":"United Kingdom","Longitude":"-0.1652792","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"NW3 2QG","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Vandoeuvre Les Nancy Cedex","Latitude":"48.661118","CountryDisplay":"France","Longitude":"6.17376","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"54511","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Toronto","Latitude":"43.6860178","CountryDisplay":"Canada","Longitude":"-79.3934523","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"M4T 3A7","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Hamilton","Latitude":"43.2573546","CountryDisplay":"Canada","Longitude":"-79.892506","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"L8N 3Z5","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"London","Latitude":"51.4673518","CountryDisplay":"United Kingdom","Longitude":"-0.0926719","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"SE5 9RS","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Madrid","Latitude":"40.3672276","CountryDisplay":"Spain","Longitude":"-3.6978264","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"28041","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Barcelona","Latitude":"41.4083076","CountryDisplay":"Spain","Longitude":"2.1720423","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"08025","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Toronto","Latitude":"43.6622852","CountryDisplay":"Canada","Longitude":"-79.3790251","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"M5B 1L6","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Darlinghurst","Latitude":"-33.8780176","CountryDisplay":"Australia","Longitude":"151.2204441","Name":"GSK Investigational Site","StateDisplay":"New South Wales","PostalCode":"2010","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Ottawa","Latitude":"45.4227425","CountryDisplay":"Canada","Longitude":"-75.6824915","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"K1N 6N5","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Montreal","Latitude":"45.4971818","CountryDisplay":"Canada","Longitude":"-73.589366","Name":"GSK Investigational Site","StateDisplay":"Quebec","PostalCode":"H3G 1A4","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Toulon","Latitude":"43.1146883","CountryDisplay":"France","Longitude":"5.9488975","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"83000","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Strasbourg","Latitude":"48.6019858","CountryDisplay":"France","Longitude":"7.7835217","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"67000","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Saint Denis Cedex 01","Latitude":"48.936181","CountryDisplay":"France","Longitude":"2.357443","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"93205","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Paris Cedex 10","Latitude":"48.856614","CountryDisplay":"France","Longitude":"2.3522219","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"75475","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Lagny sur Marne","Latitude":"48.87296","CountryDisplay":"France","Longitude":"2.713016","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"77400","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Reus","Latitude":"41.156211","CountryDisplay":"Spain","Longitude":"1.1077258","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"43201","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"London","Latitude":"51.5170141","CountryDisplay":"United Kingdom","Longitude":"-0.1742622","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"W2 1NY","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Paris Cedex 20","Latitude":"48.8575475","CountryDisplay":"France","Longitude":"2.3513765","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"75970","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Athens","Latitude":"37.9837928","CountryDisplay":"Greece","Longitude":"23.7629689","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"11527","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Vancouver","Latitude":"49.278915","CountryDisplay":"Canada","Longitude":"-123.12909","Name":"GSK Investigational Site","StateDisplay":"British Columbia","PostalCode":"V6Z 2C7","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Alicante","Latitude":"38.3616509","CountryDisplay":"Spain","Longitude":"-0.489172","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"03010","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Bobigny","Latitude":"48.908612","CountryDisplay":"France","Longitude":"2.439712","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"93009","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Piraeus","Latitude":"37.9393131","CountryDisplay":"Greece","Longitude":"23.6424563","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"18536","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Hamburg","Latitude":"53.5580847","CountryDisplay":"Germany","Longitude":"10.011979","Name":"GSK Investigational Site","StateDisplay":"Hamburg","PostalCode":"20099","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"}],"masking":"Open Label","maximum_age_raw":"N/A N/A","maximum_age":"N/A","minimum_age":"18","minimum_age_raw":"18 Years","modified_date":"10/01/2018 22:58:48","number_of_arms":"1","observational_design":{"biospecimen_description":"","biospecimen_retention":"","number_of_groups":"","observational_study_design":"","patient_registry":"","target_duration_quantity":"","target_duration_units":"","timing":""},"official_title":"See Detailed Description","org_study_id":"APV102002","overall_contact":{"email":null,"last_name":"US GSK Clinical Trials Call Center","phone":"877-379-3718"},"overall_status":"Completed - Interventional","oversight_info":{"exported_from_us":"","fda_regulated_device":"","fda_regulated_drug":"","ped_postmarket_surv":"","has_dmc":null,"post_prior_to_approval":"","regulatory_authorities":[""]},"phase":"Phase 3","primary_compl_date":null,"primary_outcomes":[{"outcome_description":"","outcome_measure":"The average area under the curve minus baseline [AAUCMB] in plasma HIV-1 RNA at 24 Weeks when each are administered in combination with an optimised background therapy, in a multiple PI-experienced population experiencing virological failure.","outcome_time_frame":"24 weeks","outcome_safety_issue":null}],"product_name":"","product_name_OneLinkTx":"","secondary_ids":[],"secondary_outcomes":[{"outcome_description":"","outcome_measure":"Efficacy (AAUCMB) at 48 weeks, safety, tolerability(incidence and nature of AEs and laboratory abnormalities) at week 24 and 48, CD4 change from baseline at week 24 and 48, and the steady-state plasma APV and LPV through concentrations.","outcome_time_frame":"48 weeks","outcome_safety_issue":null}],"sponsors":{"investigator_affiliation":"","investigator_username":"","lead_sponsor":"ViiV Healthcare","collaborators":[]},"start_date":"01/01/2005 00:00:00","study_type":"interventional","therapeutic_area":"Infectious Diseases","citations":[],"is_section_801":null}},"pageContext":{"studyId":"APV102002"}},"staticQueryHashes":["162689979","3332233851","3729204765","3769354840","399703114"]}